Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 81 |
| Active Pipeline (Recruiting Now) | 35 (20) |
| Completed vs Stopped Early | 32 / 14 (17.3%) |
| Median Closed Actual Enrollment | 36 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Top Partner U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Shared Protocols |
|---|---|---|
| Vanderbilt University Medical Center | Nashville, TN | 70 |
| University of Mississippi Medical Center | Jackson, MS | 3 |
| UC Davis Comprehensive Cancer Center | Sacramento, CA | 2 |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Vanderbilt University Medical Center across sibling Meru public-data platforms.
Explore interactive annual charts and M&A subsidiary rollups in the Vanderbilt University Medical Center Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.